AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2015
Nov 20, 2015
30786_dirs_2015-11-20_9243bca5-0598-43a4-b0a1-70dc5e6e8207.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-11-18
Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-18 | Bio-Rad A Common Stock | M | 6000 | $62.47 | Acquired | 18655 | Direct |
| 2015-11-18 | Bio-Rad A Common Stock | S | 6000 | $140.00 | Disposed | 12655 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-18 | Non-Qualified Stock Option (right to buy) | $62.47 | M | 6000 | Disposed | 2016-04-03 | Bio-Rad A Common Stock (6000) | Direct |
Footnotes
F1: The option vested in five equal annual installments beginning on April 3, 2007.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13